Primm Overview

  • Founded
  • 1990
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1
  • Investments
  • 1

Primm General Information


Provider of biotechnology services. The company's services include gene cloning and expression, DNA and RNA synthesis, DNA sequencing, peptide synthesis, monoclonal and polyclonal antibodies, and analysis of proteins and peptides.

Contact Information

Ownership Status
Financing Status
Formerly PE-Backed
Primary Industry
Primary Office
  • Via Olgettina 58
  • 20132 Milan
  • Italy
+39 02 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Primm Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Primm‘s full profile, request access.

Request a free trial

Primm Executive Team (1)

Name Title Board Seat Contact Info
Paolo Sarmientos Proprietario
To view Primm’s complete executive team members history, request access »

Primm Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 06-Jun-2008 0000000000 00.00 Biotechnology
To view Primm’s complete investments history, request access »

Primm Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000000 06-Jun-2008 0000000000 00.00 Completed
  • 3 buyers
To view Primm’s complete exits history, request access »